NAOMI VESTEL: Open Payments
NPI 1942759170 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 44 payments from 14 companies in 2025. Trend: 2023 $678 · 2024 $1,058 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 12 | $240 |
| Biogen, Inc. | 5 | $103 |
| Lilly USA, LLC | 4 | $85 |
| MILLICENT US INC | 5 | $77 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Exeltis, USA Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $31 |
| OptumHealth Care Solutions, LLC | 1 | $27 |
| Gynesonics, Inc. | 1 | $26 |
Products named: Veozah, ZURZUVAE, ZEPBOUND, Mirena, INTRAROSA, SLYND, FEMLYV, VIVIFY HEALTH CARE TEAM PORTAL 001.
Industry payments across IN — which companies pay providers there.
